Ryvu Therapeutics S.A. (WSE:RVU)
Poland
· Delayed Price · Currency is PLN 23.80
-0.55 (-2.26%)
Apr 4, 2025, 2:44 PM CET
Ryvu Therapeutics Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -111.44 | -92.11 | -83.78 | -79.08 | -31.69 | Upgrade
|
| Depreciation & Amortization | 10.5 | 10.97 | 12.9 | 12.56 | 12.36 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.13 | 3.57 | 8.93 | -0.29 | -5.36 | Upgrade
|
| Other Operating Activities | -8.09 | 7.29 | 17.04 | 22.74 | -0.43 | Upgrade
|
| Change in Accounts Receivable | -2.94 | -15.91 | -5.56 | -3.79 | 3.74 | Upgrade
|
| Change in Inventory | 0.91 | -0.36 | 0.2 | -0.28 | -0.09 | Upgrade
|
| Change in Unearned Revenue | -6.89 | 5.09 | 70.43 | -13.91 | 20.84 | Upgrade
|
| Change in Other Net Operating Assets | -11.67 | -3.09 | 1.61 | 8.77 | -10.9 | Upgrade
|
| Operating Cash Flow | -129.48 | -84.55 | 21.32 | -58.89 | -10.64 | Upgrade
|
| Capital Expenditures | -5.9 | -8.58 | -6.25 | -11.98 | -34.18 | Upgrade
|
| Investment in Securities | 127.34 | -192.61 | 4.47 | 19.98 | -21.98 | Upgrade
|
| Other Investing Activities | 15.73 | 5.65 | 2.48 | 0.06 | 0.22 | Upgrade
|
| Investing Cash Flow | 137.17 | -195.54 | 0.69 | 8.06 | -55.94 | Upgrade
|
| Long-Term Debt Issued | 94.66 | 0.13 | 1.15 | 1.02 | 0.02 | Upgrade
|
| Total Debt Issued | 94.66 | 0.13 | 1.15 | 1.02 | 0.02 | Upgrade
|
| Long-Term Debt Repaid | -0.44 | -1.79 | -2.51 | -3.21 | -3.95 | Upgrade
|
| Total Debt Repaid | -0.44 | -1.79 | -2.51 | -3.21 | -3.95 | Upgrade
|
| Net Debt Issued (Repaid) | 94.22 | -1.66 | -1.37 | -2.19 | -3.93 | Upgrade
|
| Issuance of Common Stock | - | 250.28 | - | 0.24 | 143.05 | Upgrade
|
| Other Financing Activities | -0.01 | -7.79 | -1.09 | -0.2 | -8.44 | Upgrade
|
| Financing Cash Flow | 94.21 | 240.83 | -2.46 | -2.15 | 130.69 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.24 | -4.72 | -0.87 | - | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - | Upgrade
|
| Net Cash Flow | 102.13 | -43.98 | 18.68 | -52.98 | 64.11 | Upgrade
|
| Free Cash Flow | -135.38 | -93.13 | 15.07 | -70.87 | -44.82 | Upgrade
|
| Free Cash Flow Margin | -132.78% | -138.39% | 22.01% | -200.12% | -121.28% | Upgrade
|
| Free Cash Flow Per Share | -5.86 | -4.07 | 0.82 | -3.86 | -2.67 | Upgrade
|
| Cash Interest Paid | 0.01 | 0.1 | 1.09 | 0.2 | 0.21 | Upgrade
|
| Cash Income Tax Paid | - | - | 5.46 | - | - | Upgrade
|
| Levered Free Cash Flow | 220.52 | 196.8 | -255.29 | -28.13 | -34.27 | Upgrade
|
| Unlevered Free Cash Flow | 222.9 | 196.86 | -254.61 | -27.85 | -34.03 | Upgrade
|
| Change in Net Working Capital | -10.4 | -247.02 | 240.01 | 2.12 | -10.11 | Upgrade
|
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.